Trademark: 87589827
Status Date
Wednesday, January 16, 2019
Filing Date
Wednesday, August 30, 2017
Abandoned Date
Tuesday, January 15, 2019
5 Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immuno-therapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immuno- therapies comprising polysaccharide antigens and protein-based antigens
42 Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immuno-therapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein- based antigens; research and development in the field of vaccines, namely, immuno-therapies comprising polysaccharide antigens and protein- based antigens
Jan 16, 2019
Abandonment Notice E-Mailed - Express Abandonment
Jan 16, 2019
Abandonment - Express Mailed
Jan 15, 2019
Teas Express Abandonment Received
Jul 23, 2018
Notification Of Final Refusal Emailed
Jul 23, 2018
Final Refusal E-Mailed
Jul 23, 2018
Final Refusal Written
Jun 21, 2018
Teas/Email Correspondence Entered
Jun 21, 2018
Correspondence Received In Law Office
Jun 19, 2018
Assigned To Lie
Jun 6, 2018
Teas Response To Office Action Received
Dec 6, 2017
Notification Of Non-Final Action E-Mailed
Dec 6, 2017
Non-Final Action E-Mailed
Dec 6, 2017
Non-Final Action Written
Dec 5, 2017
Assigned To Examiner
Sep 7, 2017
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24